• 1
    McInnes IB, O'Dell JR.State-of-the-art: rheumatoid arthritis [review].Ann Rheum Dis2010;69:1898906.
  • 2
    Gilston V, Blake DR, Winyard PG. Inflammatory mediators, free radicals and gene transcription. In: Winyard PG, Blake DR, Evans CH, editors.Free radicals and inflammation.Boston:Birkhauser Verlag;2000. p.8398.
  • 3
    Murphy G, Nagase H.Reappraising metalloproteinases in rheumatoid arthritis and osteoarthritis: destruction or repair?Nat Clin Pract Rheumatol2008;4:12835.
  • 4
    Winyard PG, Moody CJ, Jacob C.Oxidative activation of antioxidant defence.Trends Biochem Sci2005;30:45361.
  • 5
    Winyard PG, Ryan B, Eggleton P, Nissim A, Taylor E, Lo Faro ML, et al.Measurement and meaning of markers of reactive species of oxygen, nitrogen and sulfur in healthy human subjects and patients with inflammatory joint disease.Biochem Soc Trans2011;39:122632.
  • 6
    Bailey AJ, Sims TJ, Avery NC, Halligan EP.Non-enyzmic glycation of fibrous collagen: reaction products of glucose and ribose.Biochem J1995;305:38590.
  • 7
    Dobritzsch D, Lindh I, Uysal H, Nandakumar KS, Burkhardt H, Schneider G, et al.Crystal structure of an arthritogenic anticollagen immune complex.Arthritis Rheum2011;63:37408.
  • 8
    Holmdahl R, Bockermann R, Backlund J, Yamada H.The molecular pathogenesis of collagen-induced arthritis in mice: a model for rheumatoid arthritis.Ageing Res Rev2002;1:13547.
  • 9
    Nissim A, Winyard PG, Corrigall V, Fatah R, Perrett D, Panayi G, et al.Generation of neoantigenic epitopes after posttranslational modification of type II collagen by factors present within the inflamed joint.Arthritis Rheum2005;52:382938.
  • 10
    Pruijn GJ, Wiik A, van Venrooij WJ.The use of citrullinated peptides and proteins for the diagnosis of rheumatoid arthritis.Arthritis Res Ther2010;12:203.
  • 11
    Burkhardt H, Sehnert B, Bockermann R, Engstrom A, Kalden JR, Holmdahl R.Humoral immune response to citrullinated collagen type II determinants in early rheumatoid arthritis.Eur J Immunol2005;35:164352.
  • 12
    Snir O, Widhe M, Hermansson M, von Spee C, Lindberg J, Hensen S, et al.Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patients.Arthritis Rheum2010;62:4452.
  • 13
    Snir O, Widhe M, von Spee C, Lindberg J, Padyukov L, Lundberg K, et al.Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles.Ann Rheum Dis2009;68:73643.
  • 14
    Avouac J, Gossec L, Dougados M.Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review.Ann Rheum Dis2006;65:84551.
  • 15
    Goeb V, Dieude P, Daveau R, Thomas-L'otellier M, Jouen F, Hau F, et al.Contribution of PTPN22 1858T, TNFRII 196R and HLA-shared epitope alleles with rheumatoid factor and anti-citrullinated protein antibodies to very early rheumatoid arthritis diagnosis.Rheumatology (Oxford)2008;47:120812.
  • 16
    Schellekens GA, de Jong BA, van den Hoogen FH, van de Putte LB, van Venrooij WJ.Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies.J Clinical Invest1998;101:27381.
  • 17
    Lindstrom TM, Robinson WH.Biomarkers for rheumatoid arthritis: making it personal.Scand J Clin Lab Invest Suppl2010;242:7984.
  • 18
    Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al.The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.Arthritis Rheum1988;31:31524.
  • 19
    Prevoo ML, van 't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL.Modified disease activity scores that include twenty-eight–joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.Arthritis Rheum1995;38:448.
  • 20
    Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, et al.Development of criteria for the classification and reporting of osteoarthritis: classification of osteoarthritis of the knee.Arthritis Rheum1986;29:103949.
  • 21
    Cuzick J.A Wilcoxon-type test for trend.Stat Med1985;4:8790.
  • 22
    Deane KD, O'Donnell CI, Hueber W, Majka DS, Lazar AA, Derber LA, et al.The number of elevated cytokines and chemokines in preclinical seropositive rheumatoid arthritis predicts time to diagnosis in an age-dependent manner.Arthritis Rheum2010;62:316172.
  • 23
    Van Venrooij WJ, van Beers JJ, Pruijn GJ.Anti-CCP antibody, a marker for the early detection of rheumatoid arthritis.Ann N Y Acad Sci2008;1143:26885.
  • 24
    Goeb V, Aegerter P, Parmar R, Fardellone P, Vittecoq O, Conaghan PG, et al.Progression to rheumatoid arthritis in early inflammatory arthritis is associated with low IL-7 serum levels.Ann Rheum Dis2013;72:10326.
  • 25
    Gonzalez-Alvaro I, Ortiz AM, Alvaro-Gracia JM, Castaneda S, Diaz-Sanchez B, Carvajal I, et al.Interleukin 15 levels in serum may predict a severe disease course in patients with early arthritis.PLoS One2011;6:e29492.
  • 26
    Kolarz B, Majdan M, Dryglewska M, Darmochwal-Kolarz D.Antibodies against cyclic citrullinated peptide don't decrease after 6 months of infliximab treatment in refractory rheumatoid arthritis.Rheumatol Int2011;31:143943.
  • 27
    Ronnelid J, Wick MC, Lampa J, Lindblad S, Nordmark B, Klareskog L, et al.Longitudinal analysis of citrullinated protein/peptide antibodies (anti-CP) during 5 year follow up in early rheumatoid arthritis: anti-CP status predicts worse disease activity and greater radiological progression.Ann Rheum Dis2005;64:17449.
  • 28
    Teng YO, Wheater G, Hogan VE, Stocks P, Levarht EN, Huizinga TW, et al.Induction of long-term B-cell depletion in refractory rheumatoid arthritis patients preferentially affects autoreactive more than protective humoral immunity.Arthritis Res Ther2012;14:R57.
  • 29
    Andriopoulos NA, Mestecky J, Miller EJ, Bradley EL.Antibodies to native and denatured collagens in sera of patients with rheumatoid arthritis.Arthritis Rheum1976;19:6137.
  • 30
    Kim WU, Cho ML, Jung YO, Min SY, Park SW, Min DJ, et al.Type II collagen autoimmunity in rheumatoid arthritis.Am J Med Sci2004;327:20211.
  • 31
    Kim WU, Yoo WH, Park W, Kang YM, Kim SI, Park JH, et al.IgG antibodies to type II collagen reflect inflammatory activity in patients with rheumatoid arthritis.J Rheumatol2000;3:57581.
  • 32
    Terato K, DeArmey DA, Ye XJ, Griffiths MM, Cremer MA.The mechanism of autoantibody formation to cartilage in rheumatoid arthritis: possible cross-reaction of antibodies to dietary collagens with autologous type II collagen.Clin Immunol Immunopathol1996;79:14254.
  • 33
    Rantapaa-Dahlqvist S, de Jong BA, Berglin E, Hallmans G, Wadell G, Stenlund H, et al.Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis.Arthritis Rheum2003;48:27419.
  • 34
    Van de Stadt LA, de Koning MH, van de Stadt RJ, Wolbink G, Dijkmans BA, Hamann D, et al.Development of the anti–citrullinated protein antibody repertoire prior to the onset of rheumatoid arthritis.Arthritis Rheum2011;63:322633.
  • 35
    Sellam J, Berenbaum F.The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis.Nat Rev Rheumatol2010;6:62535.
  • 36
    Loeser RF.Aging and osteoarthritis: the role of chondrocyte senescence and aging changes in the cartilage matrix.Osteoarthritis Cartilage2009;17:9719.
  • 37
    Willett TL, Kandel R, De Croos JN, Avery NC, Grynpas MD.Enhanced levels of non-enzymatic glycation and pentosidine crosslinking in spontaneous osteoarthritis progression.Osteoarthritis Cartilage2012;20:73644.
  • 38
    Hendler A, Mulli TK, Hughes FJ, Perrett D, Bombardieri M, Houri-Haddad Y, et al.Involvement of autoimmunity in the pathogenesis of aggressive periodontitis.J Dent Res2010;89:138994.
  • 39
    Rosenthal M, Stastny P, Ziff M.Enhancement of immunoglobulin and rheumatoid factor synthesis by rheumatoid synovial effusions and synovial membrane culture supernatants.Rheumatology1975;6:879.
  • 40
    Humby F, Bombardieri M, Manzo A, Kelly S, Blades MC, Kirkham B, et al.Ectopic lymphoid structures support ongoing production of class-switched autoantibodies in rheumatoid synovium.PLoS Med2009;6:e1.
  • 41
    Hughes C, Faurholm B, Dell'Accio F, Manzo A, Seed M, Eltawil N, et al.Human single-chain variable fragment that specifically targets arthritic cartilage.Arthritis Rheum2010;62:100716.
  • 42
    Mullazehi M, Wick MC, Klareskog L, van Vollenhoven R, Ronnelid J.Anti-type II collagen antibodies are associated with early radiographic destruction in rheumatoid arthritis.Arthritis Research Ther2012;14:R100.
  • 43
    Strollo R, Rizzo P, Spoletini M, Landy R, Hughes C, Ponchel F, et al.HLA-dependent autoantibodies against post-translationally modified collagen type II in type 1 diabetes mellitus.Diabetologia2013;56:56372.
  • 44
    Stamp LK, Khalilova I, Tarr JM, Senthilmohan R, Turner R, Haigh RC, et al.Myeloperoxidase and oxidative stress in rheumatoid arthritis.Rheumatology (Oxford)2012;51:1796803.
  • 45
    Requena JR, Price DL, Thorpe SR, Baynes JW.Measurement of pentosidine in biological samples.Methods Mol Med2000;38:20917.